Prothena reported 29.95M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 146.91M 12.02M
Adamas Pharmaceuticals ADMS:US 31.53M 405K
Agios Pharmaceuticals AGIO:US $ 89.16M 66K
Akebia Therapeutics AKBA:US $ 103.64M 28.61M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
ALKERMES ALKS:US 313.8M 14.5M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Amgen AMGN:US $ 4.33B 1.37B
Biogen BIIB:US $ 1984.9M 304.4M
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Bluebird Bio BLUE:US $ 239.63M 8.68M
Exelixis EXEL:US $ 276.8M 14.63M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Intercept Pharmaceuticals ICPT:US $ 82.54M 13.28M
Intra Cellular Therapies ITCI:US $ 99.53M 10.34M
IONIS PHARMACEUT IONS:US $ 219M 11.65M
Macrogenics MGNX:US $ 68.65M 2.39M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Prothena PRTA:US 29.95M 2.17M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M
Seattle Genetics SGEN:US $ 722.02M 243.94M
Ultragenyx Pharmaceutical RARE:US $ 171.48M 1.72M
Vertex Pharmaceuticals VRTX:US $ 929.65M 901.68M
Xoma XOMA:US $ 4.28M 20K
YTE INCY:US $ 577.58M 12.7M